All Type of News
Emergence of generics in the ‘Nexium’ market suffered by modified drugs
Patent expiration has completely changed the dynamics of the market of ‘Nexium,’ a peptic ulcer treatment. Both the original and its incrementally modified drugs were not able to avoid downtrends.
The phenomenon is i...
Pharmaceutical industry’s KRW 1 trillion era competing for global pharmaceuticals
An era of KRW 1 trillion pharmaceutical sales has begun.
Last year, there were 3 pharmaceutical companies recording over KRW 1 trillion sales: Hanmi Pharm for KRW 1.3175 trillion, Green Cross for KRW 1.0478 trillion ...
Daewoong’s patent trial for ezetimibe while the patent is expiring in 2 months
Daewoong Pharmaceutical has attracted attention as filing a patent lawsuit for ‘ezetimibe,’ a substance for the MSD’s hyperlipidemia treatment, which will be expired in 2 months.
Ezetimibe is a substance contained in...
While are biopharmaceutical companies after Hanmi Pharm?While the biopharmaceutical industry has attracted high interests as the Hanmi Pharm’s technology transfers have been on everyone’s lips, a report was out from the securities in...
|
Gardasil and Cervarix are accepted for Cervical Cancer Vaccination Business
‘Gardasil’ and ‘Cervarix’ were selected as supporting vaccines for the cervical cancer vaccination and health consultation business which will be enforced from this June.
According to the industry concerned, the ‘HPV...
Patient consent is obligated to chance surgical intent
It seems hospitals and clinics must get consents from a patient and a guardian to change surgical intent from now on.
The Fair Trade Commission(Chairperson Jae-chan Jung, FTC) recently released the 2016 service plan ...
The Government announces ‘Life-sustaining Treatment Suspension Act’
The Ministry of Health and Welfare(Minister Jin-yup Jung, MOHW) announced the ‘Act on the Decision for Life Prolongation for Patients on Hospice, Palliative Care and Dying’ passed the Cabinet meeting and was proclaime...
Vaccine market of KRW 700 billion grows 8% annually, focused by premium vaccines
The vaccine market showing the size of KRW 700 billion was anticipated to have a high chance to become a blue ocean in the future as drawing an average 8% raising curve annually.
The industry expects the market, whic...
Protected by Patent-Linkage System, door of ‘Micardis Plus’ generic market opens
Domestic medium pharmaceutical companies have succeeded in avoiding the formulation patent of Micardis Plus(Boehringer Ingelheim), an antihypertensive complex.
The patent has been an obstacle for its generics to ente...
Domestic pharmaceutical companies develop salt-modified drugs of Viread in series
Dong-A ST, Chong Kun Dang, CJ HealthCare and JW Pharmaceutical are developing incrementally modified drugs of Viread(generic name: tenofovir), a chronic hepatitis B treatment.
The pharmaceutical companies have field ...
